Computational analysis of clinical and molecular markers and new theranostic possibilities in primary open-angle glaucoma
Keywords: 
Primary open-angle glaucoma
Pathogenesis
Oxidative stress
Inflammation
Apoptosis
Neurodegeneration
Theranostics
Issue Date: 
2020
Publisher: 
MDPI AG
ISSN: 
2077-0383
Note: 
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Citation: 
Pinazo-Duran, M.D. (M. Dolores); Garcia-Medina, J.J. (José Javier); Bolarín, J.M. (José M.); et al. "Computational analysis of clinical and molecular markers and new theranostic possibilities in primary open-angle glaucoma". Journal of clinical medicine. 9 (9), 2020, 3032
Abstract
Primary open-angle glaucoma (POAG) is a paramount cause of irreversible visual disability worldwide. We focus on identifying clinical and molecular facts that may help elucidating the pathogenic mechanisms of the disease. By using ophthalmological approaches (biomicroscopy, ocular fundus, optical coherence tomography, and perimetry) and experimental tests (enzyme-linked immunosorbent assay (ELISA), high performance liquid chromatography (HPLC), and Western blot/immunoblotting) directed to evaluate the oxidative stress, inflammation, apoptosis, and neurodegeneration processes, we gather information to build a network of data to perform a computational bioinformatics analysis. Our results showed strong interaction of the above players and its downstream effectors in POAG pathogenesis. In conclusion, specific risk factors were identified, and molecules involved in multiple pathways were found in relation to anterior and posterior eye segment glaucoma changes, pointing to new theranostic challenges for better managing POAG progression.

Files in This Item:
Thumbnail
File
jcm-09-03032-v2.pdf
Description
Size
2.91 MB
Format
Adobe PDF


Statistics and impact

Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.